About Acute Ischemic Stroke

IN THE MONTH FOLLOWING AN ACUTE ISCHEMIC STROKE, PATIENTS MAY BE AT RISK OF HAVING ANOTHER STROKE. LEARN HOW TO HELP REDUCE THE RISK OF ANOTHER STROKE.

Understanding Your Stroke

Surviving an acute ischemic stroke is a life-changing experience. Although your stroke was unexpected, it's important that you and your loved ones understand that a stroke may not be a one-time event.

Your stroke may have been caused by plaque rupturing in an artery, which caused platelets to become activated, stick together, and block the flow of blood and oxygen to the brain.

Plaque is mostly made up of fat, cholesterol, and other substances found in your blood. In the first 30 days after an acute ischemic stroke, you may be at risk of having another stroke.

To help reduce your risk of another stroke, your doctor will recommend a treatment plan and lifestyle changes that may apply to you. These could include:

  • changes in diet
  • changes in exercise
  • changes in habits, like smoking
Back to Top
About BRILINTA® (ticagrelor)

BRILINTA IS USED TO LOWER THE RISK OF STROKE FOR PATIENTS WITH A STROKE (ACUTE ISCHEMIC STROKE) OR MINI-STROKE (TIA)

BRILINTA is a type of medicine known as an oral antiplatelet (OAP). It helps stop platelets from sticking together and forming a clot.

IN A MAJOR CLINICAL STUDY, BRILINTA + ASPIRIN WORKED BETTER THAN ASPIRIN ALONE

This study included over 11,000 patients

Patients also took other medications commonly prescribed after a stroke

The study began within 24 hours of the acute ischemic stroke or high-risk TIA (mini-stroke) and patients were treated for up to 30 days

BRILINTA 90 MG + ASPIRIN WAS PROVEN TO HELP REDUCE THE RISK OF HAVING ANOTHER STROKE BETTER THAN ASPIRIN ALONE WITHIN THE FIRST 30 DAYS AFTER AN ACUTE ISCHEMIC STROKE OR HIGH-RISK TIA (MINI-STROKE)

Back to Top
Saving with BRILINTA® (ticagrelor)
Medicare Part D

SAVE WITH MEDICARE PART D

Majority of Medicare Part D Patients* will have a copay of less than $45 per month.

*“Patients” means covered lives [EGWP, Medicare MA, Medicare PDP, Medicare SN, Medi-Medi, PACE) at tiers 1-7 nationwide as calculated by Fingertip Formulary® data accessed on 2/16/2021. Cost comparisons do not imply comparable efficacy, safety, or FDA-approved indications.

Subject to eligibility rules. Restrictions apply.

BRILINTA® (ticagrelor) Savings Card

Eligible patients pay as low as $5

With the BRILINTA Savings Card, your monthly cost for BRILINTA could be as low as $5 each month. If you have commercial insurance, you may be eligible. Commercial insurance is sometimes referred to as "private insurance" and is typically provided by the company you work for.

Commercially insured patients. Eligible patients will pay as low as $5 for each 30-day supply for as long as their doctor prescribes BRILINTA, subject to a maximum savings of $200 per 30-day supply. Subject to eligibility rules below; restrictions apply.

How to get your BRILINTA Savings Card

Download the Savings Card to start saving on your prescription of BRILINTA.

DOWNLOAD THE CARD

Download and print the Savings Card now.

Back to Top

Savings Card Terms and Conditions

ELIGIBILITY: You may be eligible for this offer if you are insured by commercial insurance and your insurance does not cover the full cost of your prescription, or you are not insured and are responsible for the cost of your prescriptions. Patients who are enrolled in a state or federally funded prescription insurance program are not eligible for this offer. This includes patients enrolled in Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD) programs or TriCare, and patients who are Medicare eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees. If you are enrolled in a state or federally funded prescription insurance program, you may not use this savings card even if you elect to be processed as an uninsured (cash-paying) patient. This offer is not insurance, is restricted to residents of the United States and Puerto Rico, and to patients over 18 years of age.

TERMS OF USE: Eligible commercially insured patients with a valid prescription for BRILINTA® (ticagrelor) tablets who present this savings card at participating pharmacies will pay as low as $5 per 30-day supply. $200 maximum savings limit applies; patient’s out-of-pocket expense may vary. If you pay cash for your prescription, AstraZeneca will pay up to the first $100, and you will be responsible for any remaining balance, for each monthly prescription. Other restrictions may apply. Patient is responsible for applicable taxes, if any. Nontransferable, limited to one per person, cannot be combined with any other offer. Void where prohibited by law, taxed or restricted. Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer. AstraZeneca reserves the right to rescind, revoke, or amend this offer, eligibility and terms of use at any time without notice. This offer is not conditioned on any past, present or future purchase, including refills. Offer must be presented along with a valid prescription at the time of purchase. For additional details about this offer, please visit BRILINTA.com. If you have any questions regarding this offer, please call 1-800-422-5604.

BY USING THIS CARD, YOU AND YOUR PHARMACIST UNDERSTAND AND AGREE TO COMPLY WITH THESE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.

Pharmacist Instructions for a Patient with an Eligible Third Party:

For Commercially Insured/Covered Patients: Submit the claim to the primary Third-Party Payer first, then submit the balance due to Change Healthcare as a Secondary Payer COB with patient responsibility amount and a valid Other Coverage Code of 8. The patient is responsible for the first $5 and the card pays up to the next $200 per 30-day supply; patient’s out-of-pocket expenses may vary. Reimbursement will be received from Change Healthcare.

Pharmacist Instructions for a Cash-Paying Patient: Submit this claim to Change Healthcare. A valid Other Coverage Code (eg, 1) is required. The card will cover up to $100 per 30-day supply. Reimbursement will be received from Change Healthcare. Patients enrolled in a state or federally funded prescription insurance program may not use this savings card.

Valid Other Coverage Code required. For any questions regarding Change Healthcare online processing, please call the Help Desk 1-800-422-5604.

IMPORTANT SAFETY INFORMATION ABOUT BRILINTA® (ticagrelor), INCLUDING BOXED WARNINGS, FOR 60-MG AND 90-MG TABLETS Read More

BRILINTA is used to lower your chance of having, or dying from, a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. While you take BRILINTA, you may bruise and bleed more easily and be more likely to have nosebleeds. Bleeding will also take longer than usual to stop.

Approved Use

BRILINTA is a prescription medicine for people who have had a heart attack or severe chest pain that happened because their heart wasn’t getting enough oxygen.

IMPORTANT SAFETY INFORMATION ABOUT BRILINTA® (ticagrelor), INCLUDING BOXED WARNINGS, FOR 60-MG AND 90-MG TABLETS

BRILINTA is used to lower your chance of having, or dying from, a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. While you take BRILINTA, you may bruise and bleed more easily and be more likely to have nosebleeds. Bleeding will also take longer than usual to stop.

Call your doctor right away if you have any signs or symptoms of bleeding while taking BRILINTA, including: severe, uncontrollable bleeding; pink, red, or brown urine; vomit that is bloody or looks like coffee grounds; red or black stool; or if you cough up blood or blood clots.

Do not stop taking BRILINTA without talking to the doctor who prescribes it for you. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying. If you stop BRILINTA because of bleeding, or for other reasons, your risk of a heart attack or stroke may increase. Tell all your doctors and dentists that you are taking BRILINTA. To decrease your risk of bleeding, your doctor may instruct you to stop taking BRILINTA 5 days before you have surgery. Your doctor should tell you when to start taking BRILINTA again, as soon as possible after surgery.

Take BRILINTA and aspirin exactly as instructed by your doctor. In most cases, you should not take a dose of aspirin higher than 100 mg daily because it can affect how well BRILINTA works. Tell your doctor if you take other medicines that contain aspirin. Do not take new medicines that contain aspirin.

Do not take BRILINTA if you have a history of bleeding in the brain, are bleeding now, or are allergic to ticagrelor or any of the ingredients in BRILINTA.

Slow heart rhythm has been reported with BRILINTA.

BRILINTA can cause serious side effects, including bleeding, shortness of breath, and irregular breathing. Call your doctor if you have new or unexpected shortness of breath or irregular breathing, or any side effect that bothers you or does not go away. Your doctor can decide what treatment is needed.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BRILINTA may affect the way other medicines work, and other medicines may affect how BRILINTA works. Tell your doctor if you are breastfeeding or plan to breastfeed. You should not breastfeed while being treated with BRILINTA.

APPROVED USE

BRILINTA is a prescription medicine for adults used to:
  • decrease your risk of death, heart attack, and stroke in people with a blockage of blood flow to the heart (acute coronary syndrome or ACS) or a history of a heart attack. BRILINTA can also decrease your risk of blood clots in your stent in people who have received stents for the treatment of ACS.
  • decrease your risk of a first heart attack or stroke in people who have a condition where the blood flow to the heart is decreased (coronary artery disease or CAD) who are at high risk for having a heart attack or stroke.
  • decrease your risk of stroke in people who are having a stroke (acute ischemic stroke) or temporary stroke-like symptoms, known as a mini-stroke or transient ischemic attack.